Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 931 across all filing types
Latest filing 2019-05-28 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
2018年年度股东大会法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality and validity of the 2018 Annual General Meeting (AGM) of shareholders of a company. It details the procedures of the AGM, the legitimacy of the meeting convocation, attendance, voting methods, and the approval of various resolutions including reports and financial statements. It does not contain the actual annual report or financial statements but rather confirms the legality and validity of the AGM process and its outcomes. This type of document is typically classified as Declaration of Voting Results & Voting Rights Announcements (DVA) because it officially reports the results and legality of shareholder votes at the AGM.
2019-05-28 Chinese
关于使用部分自有闲置资金进行投资理财的公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement by the board of directors of a company regarding the decision to use part of its idle funds for investment and financial management. It includes details about the investment purpose, amount, scope, risk analysis, and independent directors' opinions. The document is an announcement of a corporate decision and does not contain financial statements or detailed financial performance data. It is not a report like an annual or interim report, nor is it a regulatory filing or certification. The content fits best with a Capital/Financing Update as it relates to the company's use of funds and investment activities.
2019-05-28 Chinese
2018年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a 2018 Annual General Meeting (AGM) resolution announcement for the company 马应龙药业集团股份有限公司. It details the date and location of the AGM, attendance, voting results on various proposals including the 2018 annual report, financial statements, profit distribution, election of board members, and amendments to the company bylaws. The document includes voting results and legal witness statements confirming the validity of the meeting and resolutions. The content is focused on the official announcement of the AGM resolutions and voting outcomes rather than the full annual report or financial statements themselves. The document length is about 5431 characters, which is consistent with a detailed announcement but not a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2019-05-28 Chinese
公司章程（2019年修订）
Governance Information Classification · 100% confidence The document is titled as the "Company Articles of Association" (公司章程) for MaYingLong Pharmaceutical Group Co., Ltd., with detailed chapters covering company governance, shareholder rights, board of directors, management, financial accounting, and other corporate organizational rules. It is a comprehensive legal document outlining the internal rules and governance structure of the company. There is no indication that this is an announcement, a report of financial results, or a meeting transcript. The document is a governance document specifying the company's internal rules and board structure. Therefore, it fits the category of Governance Information (CGR).
2019-05-28 Chinese
第十届董事会第一次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the first meeting of the 10th Board of Directors of 马应龙药业集团股份有限公司. It details the election and appointment of the chairman, vice chairman, general manager, financial director, board secretary, and other senior management personnel. It also includes the establishment of various committees and approval of the board's work outline and investment plans. The document is primarily about changes and appointments in the company's board and senior management, with no financial statements or earnings data presented. The document length is 2673 characters, which is relatively short and consistent with a board/management announcement rather than a full report. Therefore, the appropriate classification is Board/Management Information (MANG).
2019-05-28 Chinese
第十届监事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of a resolution from the company's supervisory board meeting, specifically about the election of the chairman of the supervisory board. It includes details about the meeting date, attendees, and the election result, along with a brief personal resume of the elected chairman. There are no financial statements, audit results, or detailed management reports. The document is a formal announcement of a board/management change rather than a full report or financial disclosure. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is short and focused on management changes, not a report or regulatory filing.
2019-05-28 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.